Hi Subscriber,

BISU, When this steamroller gets moving, our members will make 200% to 300% – THIS STOCK IS A WINNER

BISU has rallied 35.59% in two weeks.  The stock closed  @ .80 on Friday.  We are looking for the stock to rally to the $2.00 to $3.00 level.

The company has a cutting edge malaria solution which could be a blockbuster.

http://www.stockwatch.com/newsit/newsit_newsit.aspx?bid=U-i0557375-U:BISU-20091110&symbol=BISU&news_region=U

MALARIA IS AN ENORMOUS PROBLEM WORLDWIDE.

This due diligence on malaria shows you the size of the opportunity for BISU.  This company can save lives and make million for shareholders.

-                  Malaria is an infectious disease caused by parasite called Plasmodia (four species of parasite Plasmodium vivax, Plasmodium falciparum, Plasmodium ovale and Plasmodium malariae)

-                  #1 infectious killer and is the main priority of tropical disease for the World Health Organization (WHO)

-                  Malaria affects over 40% of the world’s population, in more then 100 countries in the tropics from South America to the Indian peninsula.  These parts of the world provide ideal living and breeding conditions for the anopheles mosquito.

-                  Every year 300 million to 500 million people suffer from this disease (90% of them in sub-Saharan Africa, two thirds of the remaining cases occur in six countries- India, Brazil, Sri Lanka, Vietnam, Colombia and Solomon Islands)

-                  WHO forecasts a 16% growth in malaria cases annually

-                  About 1.5 million to 3 million people die of malaria every year (85% of these occur in Africa), accounting for about 4-5% of all fatalities in the world.

-                  One child dies of malaria somewhere in Africa every 20 sec., and there is one malarial death every 12 sec somewhere in the world.

-                  Malaria kills in 1 year what AIDS killed in 15 years. In 15 years, if 5 million have died of AIDS, 50 million have died of malaria.

-                  Malaria ranks third among the major infectious diseases in causing deaths- after pneumococcal acute respiratory infections and tuberculosis.

-                  Estimated global annual cost (in 1995) for malaria: US$ 2 billion

-                  Estimated worldwide expenditure on malaria research: US$ 58 million, one thousandth of the US$ 56 billion spent globally on health research annually.

-                  Estimated annual expenditure on malaria research, prevention and treatment: $84 million.

The BISU opportunity is huge.  Once the sales get rolling it could be like a steamroller.

We think members need to sock away some BISU.  PTM thinks BISU will run 200% to 300%.

Please remember to do your due diligence on BISU.

For more information on BISU, please join us @ www.picksthatmove.com